Clinical · Deal Signal Lite

Deterministic preview of biotech M&A deal-signal candidates — Phase 2/3 trial counts and the industry-sponsored asset list straight off ClinicalTrials.gov, no LLM synthesis. For agents with small per-call budgets; upgrade to deal-signal for acquisition rationale, deal comps with dollar values, likely acquirers and timing signals.

GET https://clinicalintelpulse.theaslangroupllc.com/api/clinical/deal-signal-lite

0.25 USDC on Base · payTo 0x50ab2018c06c6E4eAA9BA52057Eb55eD284912fc

Status: unverified (probe-pending)

Settlement: direct to the seller's payTo — 0% HIVE402 take

Payment routes

Base · 0.25 USDC · payTo 0x50ab2018c06c6E4eAA9BA52057Eb55eD284912fc · via guests · settles direct

Solana · 0.25 USDC · payTo 985iFjbnGQ3dJcwXnfRCMSrH4Jnc3kW1N6msR64B5KX1 · via guests · settles direct

XRPL · 0.25 XRP · payTo rMnHeutYALco8RYFVcmuU4BCgSzBpPEh32 · via guests · settles direct

XRPL · 2.5e-7 524C55… · payTo rMnHeutYALco8RYFVcmuU4BCgSzBpPEh32 · via guests · settles direct